Alamar Biosciences, Inc. (ALMR)
CIK 2104204 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 69.4M shares as of Jul 31, 2026 (10-Q).
Cash runway
Not enough filing data
can’t compute a runway
Full breakdown: cash runway tool · source filing →
Warrants
Warrants outstanding: 31,251 underlying shares, as reported Apr 19, 2026 (10-Q).
Rough fully diluted estimate: 69.4M = 69.4M O/S + 31,251 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
Convertible debt on the balance sheet: $56.5M as of Jan 8, 2026, tagged only as a company-wide total.
This filer tagged totals without per-note dimensions in its 10-Q filed Aug 11, 2026 →, so per-note terms (maturities, individual conversion prices) live in the exhibit prose and are not parsed here.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 69.4M | Jul 31, 2026 |
| + Warrants (aggregate, as tagged) (if exercised) | 31,251 | Apr 19, 2026 |
| Fully diluted estimate | 69.4M | +0.0% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $100.0Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 1 executed · 4 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full ALMR workspace